Airtel bill pdf download update#

Except as written in any other disclaimers, policies, terms of use, or other notices on this Site, this Privacy Statement and the Terms of Use are the complete agreement between you and Ocular Therapeutix with respect to your use of this Site. Please read our Terms of Use to understand the general rules about your use of this Site. By using this Site, you agree to the terms of this Privacy Statement. We encourage you to check this page frequently by clicking on the Privacy Policy link on any page of our Site. Your continued use of the Site after any changes or revisions to this Privacy Policy shall indicate your agreement with the terms of such revised Privacy Policy. Such changes to the Privacy Policy will become effective when posted. If and when our data practices change, Ocular Therapeutix will post the revised policy on this page of our Site.

Airtel bill pdf download update#

Accordingly, we reserve the right to update or modify this policy at any time without prior notice. Because of these ongoing enhancements, changes in the law and the changing nature of technology, Ocular Therapeutix data practices will change from time to time. Ocular Therapeutix is continually improving and adding new functionality and features to this Site. This Privacy Statement (вЂњPrivacy StatementвЂќ) tells you how we protect and use information that we gather through this website located at. We also understand that privacy is very important to you. PLEASE READ THIS PRIVACY STATEMENT CAREFULLY.

You are encouraged to report Suspected Adverse Reactions. may without notice modify and/or discontinue operation of all or portions of this Site at any time in its sole discretion, and assumes no responsibility to update the Site. Without liability whatsoever Ocular Therapeutix, Inc. and shall not relieve the User from undertaking its own investigations and tests. All this information shall not, however, as far as legally permissible, create any guarantee or representation of any kind or any liability of Ocular Therapeutix, Inc. PP-US-DX-0122-V9ДЄny product/company information or other information published via the Site is given to the best of our (Ocular Therapeutix, Inc.) knowledge. All rights reserved.ДEXTENZA is a registered trademark and DEXTENZA360 is a trademark of Ocular Therapeutix, Inc. The most common non-ocular adverse reaction that occurred in patients treated with DEXTENZA was headache (1%). The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%) intraocular pressure increased (6%) visual acuity reduced (2%) cystoid macular edema (1%) corneal edema (1%) eye pain (1%) and conjunctival hyperemia (1%).

Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. Fungal culture should be taken when appropriate. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).ДЇungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. In acute purulent conditions, steroids may mask infection and enhance existing infection. Intraocular pressure should be monitored during treatment.Д¬orticosteroids may suppress the host response and thus increase the hazard for secondary ocular infections. Steroids should be used with caution in the presence of glaucoma. Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision.

DEXTENZA is contraindicated in patients with active corneal, conjunctival or canalicular infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella mycobacterial infections fungal diseases of the eye, and dacryocystitis.